
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 05 March 2019
Sec. Drugs Outcomes Research and Policies
Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.00129
This article is a correction to:
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
A Corrigendum on
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy.
by Otto, M. H., Pillarella, C., and Jommi, C. (2018). Front. Pharmacol. 9:1069. doi: 10.3389/fphar.2018.01069
In the original article, there was a mistake in Table 2 as published. The item “NON prescription (C and Cbis)”, should have been listed as “NON prescription (C)”. Additionally, there was a mistake in Figure 1 as published. The horizontal axis interval was incorrect, therefore rendering the labels ineligible. The corrected Table 2 and Figure 1 appears below.
Figure 1. Market of switchable drugs by priority (2015). *Classified as OTC at least in 3 out of 4 main European Countries.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: switch, OTC, economic impact, self-medication, pharmaceutical expenditure
Citation: Otto MH, Pillarella C and Jommi C (2019) Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy. Front. Pharmacol. 10:129. doi: 10.3389/fphar.2019.00129
Received: 24 December 2018; Accepted: 05 February 2019;
Published: 05 March 2019.
Edited and reviewed by: Philippe Van Wilder, Free University of Brussels, Belgium
Copyright © 2019 Otto, Pillarella and Jommi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Monica Hildegard Otto, bW9uaWNhLm90dG9AdW5pYm9jY29uaS5pdA==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.